FI (list display)

  • A61K51/00
  • Preparations containing radioactive substances for use in therapy or testing in vivo HB CC 4C085
  • A61K51/00,100
  • .for therapy [prohibit classfying A61K 51/00 without expansion symbol] HB CC 4C084
  • A61K51/00,200
  • .for testing [prohibit classfying A61K 51/00 without expansion symbol] HB CC 4C085
  • A61K51/02
  • .characterised by the carrier HB CC 4C085
  • A61K51/02,100
  • ..for therapy [prohibit classfying A61K 51/02 without expansion symbol] HB CC 4C084
  • A61K51/02,200
  • ..for testing [prohibit classfying A61K 51/02 without expansion symbol] HB CC 4C085
  • A61K51/04
  • ..Organic compounds HB CC 4C085
  • A61K51/04,100
  • ...for therapy [prohibit classfying A61K 51/04 without expansion symbol] HB CC 4C084
  • A61K51/04,200
  • ...for testing [prohibit classfying A61K 51/04 without expansion symbol] HB CC 4C085
  • A61K51/04,300
  • ...Sugar, nucleoside, nucleotide, oligonucleotide, nucleic acid [prohibit classfying A61K 51/04 without expansion symbol] HB CC 4C085
  • A61K51/04,310
  • ....for therapy [prohibit classfying A61K 51/04 without expansion symbol] HB CC 4C084
  • A61K51/04,320
  • ....for testing [prohibit classfying A61K 51/04 without expansion symbol] HB CC 4C085
  • A61K51/06
  • ...Macromolecular compounds HB CC 4C085
  • A61K51/06,100
  • ....for therapy [prohibit classfying A61K 51/06 without expansion symbol] HB CC 4C084
  • A61K51/06,200
  • ....for testing [prohibit classfying A61K 51/06 without expansion symbol] HB CC 4C085
  • A61K51/08
  • ...Peptides, e.g. proteins HB CC 4C085
  • A61K51/08,100
  • ....for therapy[prohibit classfying A61K 51/08 without expansion symbol] HB CC 4C084
  • A61K51/08,200
  • ....for testing [prohibit classfying A61K 51/08 without expansion symbol] HB CC 4C085
  • A61K51/10
  • ....Antibodies or immunoglobulins; Fragments thereof HB CC 4C085
  • A61K51/10,100
  • .....for therapy [prohibit classfying A61K 51/10 without expansion symbol] HB CC 4C084
  • A61K51/10,200
  • .....for testing [prohibit classfying A61K 51/10 without expansion symbol] HB CC 4C085
  • A61K51/12
  • .characterised by a special physical form, e.g. emulsion, microcapsules, liposomes HB CC 4C085
  • A61K51/12,100
  • ..for therapy [prohibit classfying A61K 51/12 without expansion symbol] HB CC 4C084
  • A61K51/12,200
  • ..for testing [prohibit classfying A61K 51/12 without expansion symbol] HB CC 4C085
    TOP